Research

Heart failure induces cardiac and stem cell aging, Mayo Clinic study finds
March 26, 2023
ROCHESTER, Minn. — Senescence is an aspect of aging that involves a biological dysfunction that occurs in response to repetitive stressors. Biological aging is associated with an increase in the incidence of cardiovascular disease, but whether heart failure is itself a senescent process indep...
Read More
Science Saturday: New standards and open access can help natural language processing
March 22, 2023
Clinical notes in medical records are rich sources of data about human health. But tapping them for medical research can be challenging because these data come from various sources — and they all look different. "There's no standardization in how data is organized and classified across medica...
Read More
‘Deaths of Despair’ contribute to 17% rise in Minnesota’s death rate during COVID-19 pandemic
March 19, 2023
ROCHESTER, Minn. — According to a new study published by Mayo Clinic researchers, the COVID-19 pandemic was linked to a 17% increase in the death rate in Minnesota during the first year of the pandemic compared to the two previous years. Deaths were driven by both COVID-19 and other causes li...
Read More
Science Saturday: Researchers elucidate details about the role of inflammation in liver regeneration
March 8, 2023
The liver has the greatest regenerative capacity of any organ in the body, making it possible for surgeons to treat cancerous and noncancerous diseases with extensive surgical approaches. However, underlying chronic liver diseases, like cirrhosis or nonalcoholic steatohepatitis, are known to in...
Read More
Obesity makes it harder to diagnose and treat heart disease
March 3, 2023
ROCHESTER, Minn. — Being overweight impacts your heart health in more ways than you might think. A new JACC review paper from Mayo Clinic outlines how obesity affects the common tests used to diagnose heart disease and impacts treatments. Cardiovascular disease is the leading cause of death i...
Read More
Mayo Clinic discovery leads to life-changing treatment for young girl with ultra-rare disease
March 3, 2023
Rare Disease Day on Feb. 28 raises awareness of the 30 million people in the U.S. who have a rare disease. Months after young Maggie Carmichael started taking an experimental drug for her ultra-rare genetic disease, she was able to trade in her wheelchair for a walker. The 9-year-old Mayo Clini...
Read More
Science Saturday: Could antidepressants cause treatment-emergent mania?
March 2, 2023
In a study published in Molecular Psychiatry, Mark Frye, M.D., a Mayo Clinic researcher and collaborators, investigated the risk of treatment-emergent mania in bipolar disorder when treated with antidepressants. "We found that antidepressants that increase mitochondrial energetics (cells that...
Read More
Science Saturday: Bioengineering vocal cords
February 22, 2023
Tissue engineering techniques discovered at Mayo Clinic and Arizona State University created a humanlike vocal cord (fold) structure with the potential to produce a natural-sounding voice. The bioengineered scaffold mimics human vocal folds, with ability to vibrate and make sound. The study tea...
Read More
Science Saturday: Can AI-enhanced heart screening address health disparities?
February 16, 2023
Clinicians and researchers around the world are combining artificial intelligence, known as AI, with health care to help identify patients at greater risk of cardiovascular diseases, such as stroke and heart failure. However, as use of these AI-enhanced tools grows, researchers at Mayo Clinic...
Read More
Science Saturday: Cross-laboratory collaboration accelerates gold-standard SRA testing
February 8, 2023
At Mayo Clinic Laboratories, where teamwork powers innovation, a cross-laboratory collaboration has enabled implementation of a cutting-edge, gold standard test for a life-threatening condition known as HIT, or heparin-induced thrombocytopenia. The test, a serotonin release assay (SRA), uses th...
Read More
Psilocybe cubensis extract potently prevents fear memory recall and freezing behavior in short- but not long-term in a rat model of posttraumatic stress disorder.
Psilocybe cubensis is a species of psilocybin mushroom (magic mushroom) of moderate potency whose principal active compounds are psilocybin and psilocin. Recent studies have shown the significant procognitive and mood-enhancer effects of Psilocybe cubensis. However, evidence is so limited, especially in preclinical studies. We aimed to investigate the effect of Psilocybe cubensis extract on posttraumatic stress disorder (PTSD)-like behavior, pain perception, locomotor activity, and anxiety in a rat model of PTSD. Male rats were exposed to three consecutive shocks (0.8 mA, 3 s interval) paired with three sounds broadcasted 3 s before delivering shocks (75 dB, 3 s). After 1, 3, or 21 days, fre...
Read Article
Sex similarities and dopaminergic differences in interval timing.
Rodent behavioral studies have largely focused on male animals, which has limited the generalizability and conclusions of neuroscience research. Working with humans and rodents, we studied sex effects during interval timing that requires participants to estimate an interval of several seconds by making motor responses. Interval timing requires attention to the passage of time and working memory for temporal rules. We found no differences between human females and males in interval timing response times (timing accuracy) or the coefficient of variance of response times (timing precision). Consistent with prior work, we also found no differences between female and male rodents in timing accura...
Read Article
Less is more: Smaller hippocampal subfield volumes predict greater improvements in posttraumatic stress disorder symptoms over 2 years.
Posttraumatic stress disorder (PTSD) is a heterogeneous disorder, and symptom severity varies over time. Neurobiological factors that predict PTSD symptoms and their chronicity remain unclear. This study investigated whether the volume of the hippocampus and its subfields, particularly cornu ammonis (CA) 1, CA3, and dentate gyrus, are associated with current PTSD symptoms and whether they predict PTSD symptom changes over 2 years. We examined clinical and structural magnetic resonance imaging measures from 252 trauma-exposed post-9/11 veterans (159 with Time 1 PTSD diagnosis) during assessments approximately 2 years apart. Automated hippocampal subfield segmentation was performed with FreeSu...
Read Article
Indirect and direct cannabinoid agonists differentially affect mesolimbic dopamine release and related behaviors.
The cannabinoid system is being researched as a potential pharmaceutical target for a multitude of disorders. The present study examined the effect of indirect and direct cannabinoid agonists on mesolimbic dopamine release and related behaviors in C57BL/6J (B6) mice. The indirect cannabinoid agonist N-arachidonoyl serotonin (AA-5-HT) indirectly agonizes the cannabinoid system by preventing the metabolism of endocannabinoids through fatty acid amide hydrolase inhibition while also inhibiting transient receptor potential vanilloid Type 1 channels. Effects of AA-5-HT were compared with the direct cannabinoid receptor Type 1 agonist arachidonoyl-2′-chloroethylamide (ACEA). In Experiment 1, mic...
Read Article
Lrp8 knockout mice fed a selenium-replete diet display subtle deficits in their spatial learning and memory function.
Selenium is an essential trace element that is delivered to the brain by the selenium transport protein selenoprotein P (SEPP1), primarily by binding to its receptor low-density lipoprotein receptor-related protein 8 (LRP8), also known as apolipoprotein E receptor 2 (ApoER2), at the blood–brain barrier. Selenium transport is required for several important brain functions, with transgenic deletion of either Sepp1 or Lrp8 resulting in severe neurological dysfunction and death in mice fed a selenium-deficient diet. Previous studies have reported that although feeding a standard chow diet can prevent these severe deficits, some motor coordination and cognitive dysfunction rem...
Read Article